Literature DB >> 12115744

Osteogenic stem cells and orthopedic engineering: summary and update.

James T Triffitt1.   

Abstract

The use of osteogenic stem cells or osteoprogenitors to reconstruct skeletal tissues is a popular area of research investigation with high potential for successful use of tissue-engineering principles in orthopedics. Recent studies demonstrate the migration of marrow-derived stem cells to skeletal sites and the proliferation and differentiation at local tissue sites and support possibilities for assessing the successful uses of human osteoprogenitors in the treatment of bone deficiency diseases. In addition, the development of gene therapy procedures in these and other conditions is now considered an achievable goal with the use of these primitive marrow cells. Copyright 2002 Wiley Periodicals, Inc. J Biomed Mater Res (Appl Biomater) 63: 384-389, 2002

Entities:  

Mesh:

Year:  2002        PMID: 12115744     DOI: 10.1002/jbm.10260

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  5 in total

1.  Steroid regulation of proliferation and osteogenic differentiation of bone marrow stromal cells: a gender difference.

Authors:  Liu Hong; Habiba Sultana; Karina Paulius; Guoquan Zhang
Journal:  J Steroid Biochem Mol Biol       Date:  2009-02-13       Impact factor: 4.292

2.  Determination of the fate and contribution of ex vivo expanded human bone marrow stem and progenitor cells for bone formation by 2.3ColGFP.

Authors:  Dezhong Yin; Zhuo Wang; Qinghong Gao; Renuka Sundaresan; Chris Parrish; Qingfen Yang; Paul H Krebsbach; Alexander C Lichtler; David W Rowe; Janet Hock; Peng Liu
Journal:  Mol Ther       Date:  2009-07-14       Impact factor: 11.454

3.  Epigenetic regulation of osteogenesis: human embryonic palatal mesenchymal cells.

Authors:  Andre Barkhordarian; Jay Sison; Riana Cayabyab; Nicole Mahanian; Francesco Chiappelli
Journal:  Bioinformation       Date:  2011-01-06

4.  Three-dimensional multipotent progenitor cell aggregates for expansion, osteogenic differentiation and 'in vivo' tracing with AAV vector serotype 6.

Authors:  J R Ferreira; M L Hirsch; L Zhang; Y Park; R J Samulski; W-S Hu; C-C Ko
Journal:  Gene Ther       Date:  2012-03-08       Impact factor: 5.250

Review 5.  Design and Biological Evaluation of Delivery Systems Containing Bisphosphonates.

Authors:  Blessing Aderibigbe; Isiaka Aderibigbe; Patricia Popoola
Journal:  Pharmaceutics       Date:  2016-12-26       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.